search
Back to results

Virtual Walking Intervention for Neuropathic Pain in Spinal Cord Injury (VRWalk)

Primary Purpose

Spinal Cord Injuries, Neuropathic Pain

Status
Recruiting
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
VR Game 1
VR Game 2
Sponsored by
Virginia Commonwealth University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Spinal Cord Injuries

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • The study will recruit individuals with complete injury (American Spinal Injury Association [ASIA] classification A) with lumbar, paraplegic, or low tetraplegic (C5-C7) injury. Additional criterial will include:

    1. persistent NP symptoms that are of daily severity of at least 4/10
    2. endorsement of more than 2 items on a 7-item Spinal Cord Injury Pain Instrument, SCIPI
    3. age of 18 - 65
    4. more than one-year post-injury

Exclusion Criteria:

  1. Not meeting injury type criteria
  2. Not meeting NP criteria
  3. Age 17 or less
  4. Less than a year following injury
  5. Inability to comprehend spoken English
  6. Prisoners

Sites / Locations

  • University of Alabama at BirminghamRecruiting
  • Virginia Commonwealth UniversityRecruiting
  • University of New South WalesRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Virtual reality (VR) game 1

Virtual reality (VR) game 2

Arm Description

Participants will be asked to play a virtual reality game twice a day for 10 days.

Participants will be asked to play a virtual reality game twice a day for 10 days.

Outcomes

Primary Outcome Measures

Change in Pain Intensity
The Numeric Rating Scale (NRS) measures pain intensity via 0-10 numeric rating scale 0-10 where 0 is no pain and 10 is the worst pain imaginable.

Secondary Outcome Measures

Change in Pain Quality
The Neuropathic Pain Scale (NPS) assesses the distinct pain qualities including sharpness, heat/cold, dullness, intensity, overall unpleasantness, and surface vs. deep pain. The NPS consists of 10 items. All the items are rated 0-10 scale, with higher score indicative of more neuropathic pain for each type of respective pain.
Change in Pain Interference
The International Spinal Cord Injury Pain Basic Data Set version 2.0 interference assesses the degree to which pain interferes with day-to-day activities, mood, and sleep. Items are scored on a 0-10 numeric rating scale and scores are summed to yield an interference score ranging from 0 to 30. Higher scores indicate greater interference from pain.
Post treatment change
The Patient Global Impression of Change is a one item 7 point Likert item assessing improvement of the participants overall status. Higher scores indicate less perceived improvement. Range of scores: 1-7
Change in mood
Mood will be assessed using the Patient Health Questionnaire-9. Participants will be asked to rate have how often they have been bothered by specific problems on a 4-point Likert scale. The items are summed to yield a score ranging from 0-27. Higher scores indicate worse mood.
Change in quality of life
Quality of life is assessed by the Satisfaction with Life Scale. This is a 5 item survey. Response options are a 7-point Likert scale. Items may be assessed individually or by summing items. Range of scores: 5-35. Higher scores indicate more satisfaction in life
Neurological changes
Functional Magnetic Resonance Imaging (fMRI) will be used to observe neurological changes. Pre and post study images will be compared by experienced researchers.

Full Information

First Posted
August 6, 2021
Last Updated
August 17, 2023
Sponsor
Virginia Commonwealth University
Collaborators
United States Department of Defense, McGuire Veterans Hospital, Immersive Experience Labs
search

1. Study Identification

Unique Protocol Identification Number
NCT05005026
Brief Title
Virtual Walking Intervention for Neuropathic Pain in Spinal Cord Injury
Acronym
VRWalk
Official Title
A Multisite Randomized Clinical Trial to Examine the Efficacy and Mechanisms of Immersive Virtual Walking Treatment for Neuropathic Pain in Spinal Cord Injury
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 23, 2021 (Actual)
Primary Completion Date
September 2024 (Anticipated)
Study Completion Date
September 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Virginia Commonwealth University
Collaborators
United States Department of Defense, McGuire Veterans Hospital, Immersive Experience Labs

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The purpose of this study is to determine if playing a virtual reality walking game can help improve neuropathic pain in adults with chronic spinal cord injury.
Detailed Description
Many people with SCI experience neuropathic pain. Neuropathic pain is often described as sharp, burning, or electric. 'Traditional' treatments often do not do a good job at reducing neuropathic pain. Therefore, it is important to see if 'non-traditional' treatments might work. Scientists think that neuropathic pain occurs in SCI because the sensations coming from the eyes and up the spinal cord to the brain do not match what the brain thinks it told the body to do. This 'mis-match' may result in changes in the brain that make neuropathic pain possible. Virtual reality walking reduces this 'mis-match.' It does this by creating the 'illusion' that the person is walking. The brain then thinks it is telling the body to walk AND the information coming from the eyes matches its instructions. This 'matching' may reverse the brain changes that made neuropathic pain possible.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injuries, Neuropathic Pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants will be randomly assigned to one of two intervention arms. Both groups receive the same number of sessions, duration of sessions, and measures procured.
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
250 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Virtual reality (VR) game 1
Arm Type
Active Comparator
Arm Description
Participants will be asked to play a virtual reality game twice a day for 10 days.
Arm Title
Virtual reality (VR) game 2
Arm Type
Active Comparator
Arm Description
Participants will be asked to play a virtual reality game twice a day for 10 days.
Intervention Type
Other
Intervention Name(s)
VR Game 1
Intervention Description
Individuals playing VR game 1 will wear a head-mounted display to allow them to visualize virtual legs in the virtual environment. When wearing the display, individuals will see the legs and arms of their virtual avatar from a first-person perspective. Individuals will engage in virtual reality sessions in their home twice daily over the course of 10 days in a two-week period. Each daily session will take approximately 30 minutes, with 5-10 minutes dedicated to the virtual walking experience. Additionally, each daily session will be scheduled a minimum of 4 hours apart.
Intervention Type
Other
Intervention Name(s)
VR Game 2
Intervention Description
Individuals playing VR game 2 will wear a head-mounted display to allow them to visualize virtual legs in the virtual environment. When wearing the display, individuals will see the legs and arms of their virtual avatar from a first-person perspective. Individuals will engage in virtual reality sessions in their home twice daily over the course of 10 days in a two-week period. Each daily session will take approximately 30 minutes, with 5-10 minutes dedicated to the virtual walking experience. Additionally, each daily session will be scheduled a minimum of 4 hours apart.
Primary Outcome Measure Information:
Title
Change in Pain Intensity
Description
The Numeric Rating Scale (NRS) measures pain intensity via 0-10 numeric rating scale 0-10 where 0 is no pain and 10 is the worst pain imaginable.
Time Frame
Baseline - final follow up (up to 18 months)
Secondary Outcome Measure Information:
Title
Change in Pain Quality
Description
The Neuropathic Pain Scale (NPS) assesses the distinct pain qualities including sharpness, heat/cold, dullness, intensity, overall unpleasantness, and surface vs. deep pain. The NPS consists of 10 items. All the items are rated 0-10 scale, with higher score indicative of more neuropathic pain for each type of respective pain.
Time Frame
Baseline - final follow up (up to 18 months)
Title
Change in Pain Interference
Description
The International Spinal Cord Injury Pain Basic Data Set version 2.0 interference assesses the degree to which pain interferes with day-to-day activities, mood, and sleep. Items are scored on a 0-10 numeric rating scale and scores are summed to yield an interference score ranging from 0 to 30. Higher scores indicate greater interference from pain.
Time Frame
Baseline - final follow up (up to 18 months)
Title
Post treatment change
Description
The Patient Global Impression of Change is a one item 7 point Likert item assessing improvement of the participants overall status. Higher scores indicate less perceived improvement. Range of scores: 1-7
Time Frame
at follow up (up to 18 months)
Title
Change in mood
Description
Mood will be assessed using the Patient Health Questionnaire-9. Participants will be asked to rate have how often they have been bothered by specific problems on a 4-point Likert scale. The items are summed to yield a score ranging from 0-27. Higher scores indicate worse mood.
Time Frame
Baseline - final follow up (up to 18 months)
Title
Change in quality of life
Description
Quality of life is assessed by the Satisfaction with Life Scale. This is a 5 item survey. Response options are a 7-point Likert scale. Items may be assessed individually or by summing items. Range of scores: 5-35. Higher scores indicate more satisfaction in life
Time Frame
Baseline - final follow up (up to 18 months)
Title
Neurological changes
Description
Functional Magnetic Resonance Imaging (fMRI) will be used to observe neurological changes. Pre and post study images will be compared by experienced researchers.
Time Frame
Baseline - 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: The study will recruit individuals with complete and incomplete injury (American Spinal Injury Association [ASIA] classification A, B, C, D) with lumbar, paraplegic, or low tetraplegic (C5-C7) injury. Additional criterial will include: persistent NP symptoms that are of daily severity of at least 4/10 for 3 or more months endorsement of more than 2 items on a 7-item Spinal Cord Injury Pain Instrument, SCIPI age of 18 or older more than one-year post-injury neuropathic pain during the last 7 days ability to move elbows against gravity must have mobile connectivity with usable service) SCIPI and DN4 scores for neuropathic pain must be 2 or more must be stable on pain medication for 1 or more months must be cleared on the VRWalk physical activity clearance scale Exclusion Criteria: Not meeting injury type criteria Not meeting NP criteria Age 17 or less Less than a year following injury Inability to comprehend spoken English Prisoners must not have motion sickness that interferes with daily life blind
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Hannah Palanchi
Phone
804-569-5965
Email
hannah.palanchi@vcuhealth.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Zina Trost, PhD
Organizational Affiliation
Virginia Commonwealth University
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Alabama at Birmingham
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35294
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rachel Cowan, PhD
Email
recowan@uabmc.edu
First Name & Middle Initial & Last Name & Degree
Rachel Cowan, PhD
Facility Name
Virginia Commonwealth University
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23236
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hannah Palanchi
Phone
804-569-5965
Email
Hannah.Palanchi@vcuhealth.org
First Name & Middle Initial & Last Name & Degree
Olivier Rolin, PhD, MD
Facility Name
University of New South Wales
City
Sydney
State/Province
New South Wales
Country
Australia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sylvia Gustin, PhD
Email
s.gustin@unsw.edu.au
First Name & Middle Initial & Last Name & Degree
Sylvia Gustin, PhD

12. IPD Sharing Statement

Learn more about this trial

Virtual Walking Intervention for Neuropathic Pain in Spinal Cord Injury

We'll reach out to this number within 24 hrs